Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Tsuji

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|August 1, 2015
[Anti- SSA/Ro and Anti-SSB/ La Antibodies in Patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 18, 2013
[Antibodies to specific nuclear antigens in patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 11, 2009
[Lymphocyte subpopulations in patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 29, 2011
[Impaired mitogen-induced lymphocyte transformation in patients with Yusho]Hiroshi Tsuji, Yasuo Ito
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 23, 2003
[Thyroid function in patients with Yusho]Hiroshi Tsuji, Yasuo Ito
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 24, 2007
[Serum levels of estradiol, progesterone and prolactin in patients with Yusho]Hiroshi Tsuji, Masaharu Ikeda
Biochemical and Biophysical Research Communications|June 27, 2002
Ile (476), a constituent of di-leucine-based motif of a major lysosomal membrane protein, LGP85/LIMP II, is important for its proper distribution in late endosomes and lysosomesNorihiko Tabuchi, Kenji Akasaki, Hiroshi Tsuji
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|January 14, 2011
[Systematic training for occupational physicians in schools of public health in the US and its application to Japan's system--Master of Public Health Program at Harvard School of Public Health]Hiroshi Tsuji, Kan Usuda, Koichi Kono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 10, 2004
[Heavy charged particles radiotherapy--mainly carbon ion beams]Takeshi Yanagi, Hiroshi Tsuji, Hirohiko Tsujii
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Clinical experience of carbon ion radiotherapy for malignant tumors]Hitoshi Ishikawa, Hiroshi Tsuji, Hirohiko Tsujii
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|August 1, 2015
[Anti- SSA/Ro and Anti-SSB/ La Antibodies in Patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 18, 2013
[Antibodies to specific nuclear antigens in patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 11, 2009
[Lymphocyte subpopulations in patients with Yusho]Hiroshi Tsuji
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|June 29, 2011
[Impaired mitogen-induced lymphocyte transformation in patients with Yusho]Hiroshi Tsuji, Yasuo Ito
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 23, 2003
[Thyroid function in patients with Yusho]Hiroshi Tsuji, Yasuo Ito
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|July 24, 2007
[Serum levels of estradiol, progesterone and prolactin in patients with Yusho]Hiroshi Tsuji, Masaharu Ikeda
Biochemical and Biophysical Research Communications|June 27, 2002
Ile (476), a constituent of di-leucine-based motif of a major lysosomal membrane protein, LGP85/LIMP II, is important for its proper distribution in late endosomes and lysosomesNorihiko Tabuchi, Kenji Akasaki, Hiroshi Tsuji
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|January 14, 2011
[Systematic training for occupational physicians in schools of public health in the US and its application to Japan's system--Master of Public Health Program at Harvard School of Public Health]Hiroshi Tsuji, Kan Usuda, Koichi Kono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 10, 2004
[Heavy charged particles radiotherapy--mainly carbon ion beams]Takeshi Yanagi, Hiroshi Tsuji, Hirohiko Tsujii
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 14, 2006
[Clinical experience of carbon ion radiotherapy for malignant tumors]Hitoshi Ishikawa, Hiroshi Tsuji, Hirohiko Tsujii
Pageof 34